Scinai Immunotherapeutics (SCNI) Preferred Shares (2024 - 2025)
Scinai Immunotherapeutics (SCNI) posted Preferred Shares of $5.6 million for Q4 2025, little changed sequentially from $5.6 million in Q2 2025, and little changed YoY from $5.6 million in Q4 2024.
Scinai Immunotherapeutics (SCNI) Preferred Shares (2024 - 2025) Analysis & Trends
Scinai Immunotherapeutics has reported Preferred Shares for 2 years, with the latest figure at $5.6 million in Q4 2025.
- Quarterly Preferred Shares changed 0.0% year-over-year to $5.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.6 million (changed 0.0% YoY) and the FY2025 annual result came in at $5.6 million, changed 0.0% from the prior year.
- Preferred Shares was little changed at $5.6 million in Q4 2025 per SCNI's latest filing, from $5.6 million in the prior quarter.
- Over five years, Preferred Shares peaked at $5.6 million in Q4 2024 and troughed at $5.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.63 Mn |
| Jun 30, 2025 | 5.63 Mn |
| Dec 31, 2024 | 5.63 Mn |